| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |